IL13Rα2, a high-affinity IL-13 receptor that is typically overexpressed on glioblastoma cells and barely expressed on healthy brain tissue, was one of the first targets for CAR T cell therapy of brain tumors. The gene discussed is IL13RA2; the disease is glioblastoma.